Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEG-rhGH Safety and Efficacy in Adult Growth Hormone Deficiency
NCT03104010Phase 2Unknown
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Start
- Apr 2017
- Primary completion
- Feb 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of peg-somatropin in adult growth hormone deficiency (AGHD), sponsored by Changchun GeneScience Pharmaceutical Co., Ltd.. Status: unknown.
02
Drugs
peg-somatropin
03
Conditions
adult growth hormone deficiency (AGHD)
Beyond the preview
Go deeper on NCT03104010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03104010.